Clinical Trial Update: Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial of Sustained Acoustic Medicine (SAM) for symptomatic knee pain due to osteoarthritis has completed, with results posted on 2025-05-15.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Osteoarthritis

Drugs mentioned

• Sustained Acoustic Medicine (SAM) device

Snippet

Sponsor: ZetrOZ, Inc. | Conditions: Osteo Arthritis Knee, Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2025-05-15